 | • レポートコード：20QY06-01258 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、オルニチントランスカルバミラーゼ欠乏症のグローバル市場について種類別（DTX301、SE313、SHP641、PRX-OTC、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・オルニチントランスカルバミラーゼ欠乏症市場の概要 ・世界の主要地域別オルニチントランスカルバミラーゼ欠乏症市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のオルニチントランスカルバミラーゼ欠乏症市場規模2015-2026：種類別（DTX301、SE313、SHP641、PRX-OTC、その他） ・世界のオルニチントランスカルバミラーゼ欠乏症市場規模2015-2026：用途別（病院、クリニック、その他） ・オルニチントランスカルバミラーゼ欠乏症の北米市場規模2015-2020 ・オルニチントランスカルバミラーゼ欠乏症のヨーロッパ市場規模2015-2020 ・オルニチントランスカルバミラーゼ欠乏症の中国市場規模2015-2020 ・オルニチントランスカルバミラーゼ欠乏症の日本市場規模2015-2020 ・オルニチントランスカルバミラーゼ欠乏症の東南アジア市場規模2015-2020 ・オルニチントランスカルバミラーゼ欠乏症のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Lucane Pharma SA、PhaseRx Inc、Promethera Biosciences SA、Selecta Biosciences Inc、Translate Bio Inc、Ultragenyx Pharmaceutical Inc、Unicyte AG） ・オルニチントランスカルバミラーゼ欠乏症の製造コスト分析 ・販売チャネル、流通業者、顧客 ・オルニチントランスカルバミラーゼ欠乏症の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Ornithine-Transcarbamylase Deficiency Market
The global Ornithine-Transcarbamylase Deficiency market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Ornithine-Transcarbamylase Deficiency Scope and Market Size
The global Ornithine-Transcarbamylase Deficiency market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ornithine-Transcarbamylase Deficiency market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Ornithine-Transcarbamylase Deficiency market is segmented into
DTX-301
SEL-313
SHP-641
PRX-OTC
Others
Segment by Application, the Ornithine-Transcarbamylase Deficiency market is segmented into
Hospital
Clinic
Others
The Ornithine-Transcarbamylase Deficiency market is analysed and market size information is provided by regions (countries). Segment by Application, the Ornithine-Transcarbamylase Deficiency market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ornithine-Transcarbamylase Deficiency Market Share Analysis
Ornithine-Transcarbamylase Deficiency market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ornithine-Transcarbamylase Deficiency business, the date to enter into the Ornithine-Transcarbamylase Deficiency market, Ornithine-Transcarbamylase Deficiency product introduction, recent developments, etc.
The major vendors covered:
Lucane Pharma SA
PhaseRx Inc
Promethera Biosciences SA
Selecta Biosciences Inc
Translate Bio Inc
Ultragenyx Pharmaceutical Inc
Unicyte AG
…
Table of Contents
1 Ornithine-Transcarbamylase Deficiency Market Overview
1.1 Ornithine-Transcarbamylase Deficiency Product Scope
1.2 Ornithine-Transcarbamylase Deficiency Segment by Type
1.2.1 Global Ornithine-Transcarbamylase Deficiency Sales by Type (2020-2026)
1.2.2 DTX-301
1.2.3 SEL-313
1.2.4 SHP-641
1.2.5 PRX-OTC
1.2.6 Others
1.3 Ornithine-Transcarbamylase Deficiency Segment by Application
1.3.1 Global Ornithine-Transcarbamylase Deficiency Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Ornithine-Transcarbamylase Deficiency Market Estimates and Forecasts (2015-2026)
1.4.1 Global Ornithine-Transcarbamylase Deficiency Sales Growth Rate (2015-2026)
1.4.2 Global Ornithine-Transcarbamylase Deficiency Revenue and Growth Rate (2015-2026)
1.4.3 Global Ornithine-Transcarbamylase Deficiency Price Trends (2015-2026)
2 Ornithine-Transcarbamylase Deficiency Estimate and Forecast by Region
2.1 Global Ornithine-Transcarbamylase Deficiency Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Ornithine-Transcarbamylase Deficiency Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Ornithine-Transcarbamylase Deficiency Sales Market Share by Region (2015-2020)
2.2.2 Global Ornithine-Transcarbamylase Deficiency Revenue Market Share by Region (2015-2020)
2.3 Global Ornithine-Transcarbamylase Deficiency Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Ornithine-Transcarbamylase Deficiency Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Ornithine-Transcarbamylase Deficiency Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Ornithine-Transcarbamylase Deficiency Estimates and Projections (2015-2026)
2.4.2 Europe Ornithine-Transcarbamylase Deficiency Estimates and Projections (2015-2026)
2.4.3 China Ornithine-Transcarbamylase Deficiency Estimates and Projections (2015-2026)
2.4.4 Japan Ornithine-Transcarbamylase Deficiency Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Ornithine-Transcarbamylase Deficiency Estimates and Projections (2015-2026)
2.4.6 India Ornithine-Transcarbamylase Deficiency Estimates and Projections (2015-2026)
3 Global Ornithine-Transcarbamylase Deficiency Competition Landscape by Players
3.1 Global Top Ornithine-Transcarbamylase Deficiency Players by Sales (2015-2020)
3.2 Global Top Ornithine-Transcarbamylase Deficiency Players by Revenue (2015-2020)
3.3 Global Ornithine-Transcarbamylase Deficiency Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ornithine-Transcarbamylase Deficiency as of 2019)
3.4 Global Ornithine-Transcarbamylase Deficiency Average Price by Company (2015-2020)
3.5 Manufacturers Ornithine-Transcarbamylase Deficiency Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Ornithine-Transcarbamylase Deficiency Players (Opinion Leaders)
4 Global Ornithine-Transcarbamylase Deficiency Market Size by Type
4.1 Global Ornithine-Transcarbamylase Deficiency Historic Market Review by Type (2015-2020)
4.1.1 Global Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
4.1.2 Global Ornithine-Transcarbamylase Deficiency Revenue Market Share by Type (2015-2020)
4.1.3 Global Ornithine-Transcarbamylase Deficiency Price by Type (2014-2020)
4.2 Global Ornithine-Transcarbamylase Deficiency Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Ornithine-Transcarbamylase Deficiency Sales Forecast by Type (2021-2026)
4.2.2 Global Ornithine-Transcarbamylase Deficiency Revenue Forecast by Type (2021-2026)
4.2.3 Global Ornithine-Transcarbamylase Deficiency Price Forecast by Type (2021-2026)
5 Global Ornithine-Transcarbamylase Deficiency Market Size by Application
5.1 Global Ornithine-Transcarbamylase Deficiency Historic Market Review by Application (2015-2020)
5.1.1 Global Ornithine-Transcarbamylase Deficiency Sales Market Share by Application (2015-2020)
5.1.2 Global Ornithine-Transcarbamylase Deficiency Revenue Market Share by Application (2015-2020)
5.1.3 Global Ornithine-Transcarbamylase Deficiency Price by Application (2015-2020)
5.2 Global Ornithine-Transcarbamylase Deficiency Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Ornithine-Transcarbamylase Deficiency Sales Forecast by Application (2021-2026)
5.2.2 Global Ornithine-Transcarbamylase Deficiency Revenue Forecast by Application (2021-2026)
5.2.3 Global Ornithine-Transcarbamylase Deficiency Price Forecast by Application (2021-2026)
3 North America Ornithine-Transcarbamylase Deficiency Market Facts & Figures
3.2 North America Ornithine-Transcarbamylase Deficiency Sales Market Share by Company (2015-2020)
3.3 North America Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
3.4 North America Ornithine-Transcarbamylase Deficiency Sales Market Share by Application (2015-2020)
4 Europe Ornithine-Transcarbamylase Deficiency Market Facts & Figures
4.2 Europe Ornithine-Transcarbamylase Deficiency Sales Market Share by Company (2015-2020)
4.3 Europe Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
4.4 Europe Ornithine-Transcarbamylase Deficiency Sales Market Share by Application (2015-2020)
5 China Ornithine-Transcarbamylase Deficiency Market Facts & Figures
5.2 China Ornithine-Transcarbamylase Deficiency Sales Market Share by Company (2015-2020)
5.3 China Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
5.4 China Ornithine-Transcarbamylase Deficiency Sales Market Share by Application (2015-2020)
6 Japan Ornithine-Transcarbamylase Deficiency Market Facts & Figures
6.2 Japan Ornithine-Transcarbamylase Deficiency Sales Market Share by Company (2015-2020)
6.3 Japan Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
6.4 Japan Ornithine-Transcarbamylase Deficiency Sales Market Share by Application (2015-2020)
7 Southeast Asia Ornithine-Transcarbamylase Deficiency Market Facts & Figures
7.2 Southeast Asia Ornithine-Transcarbamylase Deficiency Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Ornithine-Transcarbamylase Deficiency Sales Market Share by Application (2015-2020)
8 India Ornithine-Transcarbamylase Deficiency Market Facts & Figures
8.2 India Ornithine-Transcarbamylase Deficiency Sales Market Share by Company (2015-2020)
8.3 India Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
8.4 India Ornithine-Transcarbamylase Deficiency Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Ornithine-Transcarbamylase Deficiency Business
12.1 Lucane Pharma SA
12.1.1 Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Corporation Information
12.1.2 Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Business Overview and Total Revenue
12.1.3 Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Products Offered
12.1.5 Lucane Pharma SA Recent Development
12.2 PhaseRx Inc
12.2.1 PhaseRx Inc Ornithine-Transcarbamylase Deficiency Corporation Information
12.2.2 PhaseRx Inc Ornithine-Transcarbamylase Deficiency Business Overview and Total Revenue
12.2.3 PhaseRx Inc Ornithine-Transcarbamylase Deficiency Sales, Revenue and Gross Margin (2015-2020)
12.2.4 PhaseRx Inc Ornithine-Transcarbamylase Deficiency Products Offered
12.2.5 PhaseRx Inc Recent Development
12.3 Promethera Biosciences SA
12.3.1 Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Corporation Information
12.3.2 Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Business Overview and Total Revenue
12.3.3 Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Products Offered
12.3.5 Promethera Biosciences SA Recent Development
12.4 Selecta Biosciences Inc
12.4.1 Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Corporation Information
12.4.2 Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Business Overview and Total Revenue
12.4.3 Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Products Offered
12.4.5 Selecta Biosciences Inc Recent Development
12.5 Translate Bio Inc
12.5.1 Translate Bio Inc Ornithine-Transcarbamylase Deficiency Corporation Information
12.5.2 Translate Bio Inc Ornithine-Transcarbamylase Deficiency Business Overview and Total Revenue
12.5.3 Translate Bio Inc Ornithine-Transcarbamylase Deficiency Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Translate Bio Inc Ornithine-Transcarbamylase Deficiency Products Offered
12.5.5 Translate Bio Inc Recent Development
12.6 Ultragenyx Pharmaceutical Inc
12.6.1 Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Corporation Information
12.6.2 Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Business Overview and Total Revenue
12.6.3 Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Products Offered
12.6.5 Ultragenyx Pharmaceutical Inc Recent Development
12.7 Unicyte AG
12.7.1 Unicyte AG Ornithine-Transcarbamylase Deficiency Corporation Information
12.7.2 Unicyte AG Ornithine-Transcarbamylase Deficiency Business Overview and Total Revenue
12.7.3 Unicyte AG Ornithine-Transcarbamylase Deficiency Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Unicyte AG Ornithine-Transcarbamylase Deficiency Products Offered
12.7.5 Unicyte AG Recent Development
…
13 Ornithine-Transcarbamylase Deficiency Manufacturing Cost Analysis
13.1 Ornithine-Transcarbamylase Deficiency Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Ornithine-Transcarbamylase Deficiency
13.4 Ornithine-Transcarbamylase Deficiency Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Ornithine-Transcarbamylase Deficiency Distributors List
14.3 Ornithine-Transcarbamylase Deficiency Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Ornithine-Transcarbamylase Deficiency Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Ornithine-Transcarbamylase Deficiency Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Ornithine-Transcarbamylase Deficiency Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Region (2015-2020)
Table 5. Global Ornithine-Transcarbamylase Deficiency Sales Market Share by Region (2015-2020)
Table 6. Global Ornithine-Transcarbamylase Deficiency Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Ornithine-Transcarbamylase Deficiency Revenue Share by Region (2015-2020)
Table 8. Global Ornithine-Transcarbamylase Deficiency Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Ornithine-Transcarbamylase Deficiency Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Ornithine-Transcarbamylase Deficiency Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Ornithine-Transcarbamylase Deficiency Revenue Share Forecast by Region (2021-2026)
Table 12. Global Ornithine-Transcarbamylase Deficiency (K Pcs) of Key Companies (2015-2020)
Table 13. Global Ornithine-Transcarbamylase Deficiency Sales Share by Company (2015-2020)
Table 14. Global Ornithine-Transcarbamylase Deficiency Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Ornithine-Transcarbamylase Deficiency Revenue Share by Company (2015-2020)
Table 16. Global Ornithine-Transcarbamylase Deficiency by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ornithine-Transcarbamylase Deficiency as of 2019)
Table 17. Global Ornithine-Transcarbamylase Deficiency Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Ornithine-Transcarbamylase Deficiency Manufacturing Sites and Area Served
Table 19. Manufacturers Ornithine-Transcarbamylase Deficiency Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Ornithine-Transcarbamylase Deficiency Players
Table 22. Global Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Type (2015-2020)
Table 23. Global Ornithine-Transcarbamylase Deficiency Sales Share by Type (2015-2020)
Table 24. Global Ornithine-Transcarbamylase Deficiency Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Ornithine-Transcarbamylase Deficiency Price (K Pcs) by Type (2015-2020)
Table 26. Global Ornithine-Transcarbamylase Deficiency Sales Share by Type (2021-2026)
Table 27. Global Ornithine-Transcarbamylase Deficiency Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Ornithine-Transcarbamylase Deficiency Revenue Share by Type (2021-2026)
Table 29. Global Ornithine-Transcarbamylase Deficiency Price (K Pcs) by Type (2021-2026)
Table 30. Global Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Application (2015-2020)
Table 31. Global Ornithine-Transcarbamylase Deficiency Sales Share by Application (2015-2020)
Table 32. Global Ornithine-Transcarbamylase Deficiency Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Ornithine-Transcarbamylase Deficiency Price (K Pcs) by Application (2015-2020)
Table 34. Global Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Application (2021-2026)
Table 35. Global Ornithine-Transcarbamylase Deficiency Sales Share by Application (2021-2026)
Table 36. Global Ornithine-Transcarbamylase Deficiency Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Ornithine-Transcarbamylase Deficiency Revenue Share by Application (2021-2026)
Table 38. Global Ornithine-Transcarbamylase Deficiency Price (K Pcs) by Application (2021-2026)
Table 39. United States Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Company (2015-2020)
Table 40. United States Ornithine-Transcarbamylase Deficiency Sales Market Share by Company (2015-2020)
Table 41. United States Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Type (2015-2020)
Table 42. United States Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
Table 43. United States Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Application (2015-2020)
Table 44. United States Ornithine-Transcarbamylase Deficiency Sales Market Share by Application (2015-2020)
Table 45. Europe Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Ornithine-Transcarbamylase Deficiency Sales Market Share by Company (2015-2020)
Table 47. Europe Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
Table 49. Europe Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
Table 51. China Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Company (2015-2020)
Table 52. China Ornithine-Transcarbamylase Deficiency Sales Market Share by Company (2015-2020)
Table 53. China Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Type (2015-2020)
Table 54. China Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
Table 55. China Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Application (2015-2020)
Table 56. China Ornithine-Transcarbamylase Deficiency Sales Market Share by Application (2015-2020)
Table 57. Japan Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Ornithine-Transcarbamylase Deficiency Sales Market Share by Company (2015-2020)
Table 59. Japan Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
Table 61. Japan Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Ornithine-Transcarbamylase Deficiency Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Ornithine-Transcarbamylase Deficiency Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Ornithine-Transcarbamylase Deficiency Sales Market Share by Application (2015-2020)
Table 69. India Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Company (2015-2020)
Table 70. India Ornithine-Transcarbamylase Deficiency Sales Market Share by Company (2015-2020)
Table 71. India Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Type (2015-2020)
Table 72. India Ornithine-Transcarbamylase Deficiency Sales Market Share by Type (2015-2020)
Table 73. India Ornithine-Transcarbamylase Deficiency Sales (K Pcs) by Application (2015-2020)
Table 74. India Ornithine-Transcarbamylase Deficiency Sales Market Share by Application (2015-2020)
Table 75. Lucane Pharma SA Corporation Information
Table 76. Lucane Pharma SA Description and Business Overview
Table 77. Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Product
Table 79. Lucane Pharma SA Recent Development
Table 80. PhaseRx Inc Corporation Information
Table 81. PhaseRx Inc Description and Business Overview
Table 82. PhaseRx Inc Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. PhaseRx Inc Ornithine-Transcarbamylase Deficiency Product
Table 84. PhaseRx Inc Recent Development
Table 85. Promethera Biosciences SA Corporation Information
Table 86. Promethera Biosciences SA Description and Business Overview
Table 87. Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Product
Table 89. Promethera Biosciences SA Recent Development
Table 90. Selecta Biosciences Inc Corporation Information
Table 91. Selecta Biosciences Inc Description and Business Overview
Table 92. Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Product
Table 94. Selecta Biosciences Inc Recent Development
Table 95. Translate Bio Inc Corporation Information
Table 96. Translate Bio Inc Description and Business Overview
Table 97. Translate Bio Inc Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Translate Bio Inc Ornithine-Transcarbamylase Deficiency Product
Table 99. Translate Bio Inc Recent Development
Table 100. Ultragenyx Pharmaceutical Inc Corporation Information
Table 101. Ultragenyx Pharmaceutical Inc Description and Business Overview
Table 102. Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Product
Table 104. Ultragenyx Pharmaceutical Inc Recent Development
Table 105. Unicyte AG Corporation Information
Table 106. Unicyte AG Description and Business Overview
Table 107. Unicyte AG Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Unicyte AG Ornithine-Transcarbamylase Deficiency Product
Table 109. Unicyte AG Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Ornithine-Transcarbamylase Deficiency Distributors List
Table 113. Ornithine-Transcarbamylase Deficiency Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Ornithine-Transcarbamylase Deficiency Product Picture
Figure 2. Global Ornithine-Transcarbamylase Deficiency Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Ornithine-Transcarbamylase Deficiency Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Ornithine-Transcarbamylase Deficiency Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Ornithine-Transcarbamylase Deficiency Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Ornithine-Transcarbamylase Deficiency Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Ornithine-Transcarbamylase Deficiency Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Ornithine-Transcarbamylase Deficiency Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Ornithine-Transcarbamylase Deficiency Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Ornithine-Transcarbamylase Deficiency Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Ornithine-Transcarbamylase Deficiency Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Ornithine-Transcarbamylase Deficiency Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Ornithine-Transcarbamylase Deficiency Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Ornithine-Transcarbamylase Deficiency Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Ornithine-Transcarbamylase Deficiency Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Ornithine-Transcarbamylase Deficiency Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Ornithine-Transcarbamylase Deficiency Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Ornithine-Transcarbamylase Deficiency Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Ornithine-Transcarbamylase Deficiency Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Ornithine-Transcarbamylase Deficiency Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Ornithine-Transcarbamylase Deficiency Players Market Share by Revenue in Ornithine-Transcarbamylase Deficiency 2015 & 2019
Figure 27. Ornithine-Transcarbamylase Deficiency Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Ornithine-Transcarbamylase Deficiency Revenue Share by Type (2015-2020)
Figure 29. Global Ornithine-Transcarbamylase Deficiency Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Ornithine-Transcarbamylase Deficiency Revenue Share by Application (2015-2020)
Figure 31. Global Ornithine-Transcarbamylase Deficiency Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Ornithine-Transcarbamylase Deficiency Sales Market Share by Type in 2019
Figure 33. United States Ornithine-Transcarbamylase Deficiency Sales Market Share by Type in 2019
Figure 34. Europe Ornithine-Transcarbamylase Deficiency Sales Market Share by Company in 2019
Figure 35. Europe Ornithine-Transcarbamylase Deficiency Sales Market Share by Type in 2019
Figure 36. Europe Ornithine-Transcarbamylase Deficiency Sales Market Share by Application in 2019
Figure 37. China Ornithine-Transcarbamylase Deficiency Sales Market Share by Company in 2019
Figure 38. China Ornithine-Transcarbamylase Deficiency Sales Market Share by Type in 2019
Figure 39. China Ornithine-Transcarbamylase Deficiency Sales Market Share by Application in 2019
Figure 40. Japan Ornithine-Transcarbamylase Deficiency Sales Market Share by Company in 2019
Figure 41. Japan Ornithine-Transcarbamylase Deficiency Sales Market Share by Type in 2019
Figure 42. Japan Ornithine-Transcarbamylase Deficiency Sales Market Share by Application in 2019
Figure 43. Southeast Asia Ornithine-Transcarbamylase Deficiency Sales Market Share by Company in 2019
Figure 44. Southeast Asia Ornithine-Transcarbamylase Deficiency Sales Market Share by Type in 2019
Figure 45. Southeast Asia Ornithine-Transcarbamylase Deficiency Sales Market Share by Application in 2019
Figure 46. India Ornithine-Transcarbamylase Deficiency Sales Market Share by Company in 2019
Figure 47. India Ornithine-Transcarbamylase Deficiency Sales Market Share by Type in 2019
Figure 48. India Ornithine-Transcarbamylase Deficiency Sales Market Share by Application in 2019
Figure 49. Lucane Pharma SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. PhaseRx Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Promethera Biosciences SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Selecta Biosciences Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Translate Bio Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Ultragenyx Pharmaceutical Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Unicyte AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Ornithine-Transcarbamylase Deficiency
Figure 58. Manufacturing Process Analysis of Ornithine-Transcarbamylase Deficiency
Figure 59. Ornithine-Transcarbamylase Deficiency Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
フィブリノーゲン欠乏症薬の世界市場レポート2020 Market Analysis and Insights: Global Fibrinogen Deficiency Drug Market The global Fibrinogen Deficiency Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Fibrinogen Deficiency Drug Scope and Market Siz…- L-オルニチンHClの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global L-Ornithine HCl market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The L-Ornithine HCl market report…
- ヒト成長ホルモンの世界市場レポート2020 Market Analysis and Insights: Global Human Somatotropin Market The global Human Somatotropin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Human Somatotropin Scope and Market Size The global Human Somat…
- 多嚢胞性卵巣症候群の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Polycystic Ovary Syndrome market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Polycystic Ovary Sy…
- メチルマロン酸の世界市場レポート2020 Methylmalonic Acid (MMA) is a dicarboxylic acid that is a C-methylated derivative of malonate. Market Analysis and Insights: Global Methylmalonic Acid Market The global Methylmalonic Acid market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR …